StockData
Ardelyx, Inc. logo

Ardelyx, Inc. (ARDX) stock

ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3058% below fair value
$3.18+0.11 (+3.58%)

Close on Nov 17, 2026Market cap $792.42MP/E –Yield –

Ardelyx pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Ardelyx's pe ratio was 819.0× on Oct 30, 2015.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2015Oct 30, 2015819.0×–

More Ardelyx figures

See a number that looks wrong?